Bill Would End Tax Increases For Companies Researching Disease
Now that the state has a projected one-time surplus of $15 billion this year, influential Democratic lawmakers want to rescind tax hikes — but only for life sciences companies that research and develop treatments for COVID-19 and other diseases.